July 2010

Rheonix CARD™ Technology Demonstrates Utility in Multiple Molecular Diagnostic Applications at AACC Annual Meeting

Ithaca, NY — July 27, 2010 — Rheonix, Inc. today announced positive results from three separate studies of the Rheonix CARD™ (Chemistry And Reagent Device) system presented in poster sessions at the American Association for Clinical Chemistry (AACC) Annual Meeting held in Anaheim, CA, July 25-29, 2010. The data presented demonstrate the utility of the Rheonix CARD™ system as a powerful, analytic platform for the life science industry. In studies… Read More »
Rheonix receives FDA Emergency Use Authorization for Automated COVID-19 Test.
Learn More